Coagulant Therapeutics Corporation
PrivateTotal Funding Raised
$36M
Company Overview
Coagulant Therapeutics Corporation is a biotechnology company that develops novel therapeutics targeted to the coagulation cascade for the treatment of acute bleeding and related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coagulant Therapeutics Corporation Comparables
Compare Coagulant Therapeutics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cayuga Biotech | 78% | |
| VarmX | 75% | |
| Novo Nordisk | 66% |
Coagulant Therapeutics Corporation Funding Rounds
Historical fundraising activity
Coagulant Therapeutics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Financial Group | Series A |
| Digital Transformation Capital Partners | Series A |
| Korea Omega Investment Corp | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 72% MoM.
- Jun 4, 2025
Grew 133% QoQ from 3 to 7 employees.
Coagulant Therapeutics Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Coagulant Therapeutics Corporation's valuation, stock price, and market status.
Is Coagulant Therapeutics Corporation a public or private company?
Coagulant Therapeutics Corporation is a private company.
What is the current stock price of Coagulant Therapeutics Corporation?
Coagulant Therapeutics Corporation is a private company with no public stock price. Caplight tracks Coagulant Therapeutics Corporation's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Coagulant Therapeutics Corporation worth (valuation)?
Valuation information for Coagulant Therapeutics Corporation is not publicly available.
Can I buy Coagulant Therapeutics Corporation stock?
Coagulant Therapeutics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Coagulant Therapeutics Corporation's last funding round?
Funding round information for Coagulant Therapeutics Corporation is not publicly available.
Who are the main investors in Coagulant Therapeutics Corporation?
Key investors in Coagulant Therapeutics Corporation include Hana Financial Group, Digital Transformation Capital Partners, Korea Omega Investment Corp.
Will Coagulant Therapeutics Corporation IPO soon?
No public IPO plans have been announced for Coagulant Therapeutics Corporation.
How can I track Coagulant Therapeutics Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Coagulant Therapeutics Corporation's secondary market activity and sign up for updates.